Home > Boards > US Listed > Medical - Healthcare > China Cord Blood Corp (CO)

China Cord Blood Corporation Files Its Annual Report

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 541
Posts 24,585
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 9/23/2019 8:50:38 AM
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019 PR Newswire (US) - 9/20/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/27/2019 4:25:21 PM
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020 PR Newswire (US) - 8/27/2019 4:16:00 PM
The Committee for China Cord Fairness Launches Consent Solicitation at Global Cord Blood Corporation PR Newswire (US) - 8/27/2019 9:00:00 AM
Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results PR Newswire (US) - 8/21/2019 7:00:00 AM
Amended Annual and Transition Report (foreign Private Issuer) (20-f/a) Edgar (US Regulatory) - 8/14/2019 6:35:20 AM
Global Cord Blood Corporation (NYSE: CO) Urged To Explain Management Compensation in Third Letter From Shareholder Group PR Newswire (US) - 8/7/2019 9:00:00 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 7/23/2019 4:19:02 PM
Global Cord Blood Corporation Files Its Annual Report on Form 20-F PR Newswire (US) - 7/23/2019 4:16:00 PM
Global Cord Blood Corporation (NYSE: CO) Urged in Second Letter From Shareholder Group to Protect Minority Shareholders PR Newswire (US) - 7/17/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/18/2019 4:34:04 PM
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019 PR Newswire (US) - 6/18/2019 4:16:00 PM
Shareholder of Global Cord Blood Corporation (NYSE: CO) Hires Global Law Firm, The Seiden Group, to Help Investigate and Enfo... PR Newswire (US) - 6/17/2019 10:56:00 PM
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results PR Newswire (US) - 6/11/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/6/2019 6:12:14 AM
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal PR Newswire (US) - 6/6/2019 6:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/4/2019 8:28:45 AM
Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company PR Newswire (US) - 6/4/2019 8:16:00 AM
Global Cord Blood Corporation Raised Subscription Fee PR Newswire (US) - 4/1/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/25/2019 4:26:57 PM
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019 PR Newswire (US) - 2/25/2019 4:16:00 PM
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results PR Newswire (US) - 2/19/2019 6:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 6:05:33 AM
Amended Report of Foreign Issuer (6-k/a) Edgar (US Regulatory) - 12/7/2018 7:06:14 AM
KarinCA Member Level  Thursday, 09/29/11 12:08:56 PM
Re: mkendra post# 377
Post # of 429 
China Cord Blood Corporation Files Its Annual Report on Form 20-F

http://ih.advfn.com/p.php?pid=nmona&article=49342453&symbol=CO

China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has filed with the U.S. Securities and Exchange Commission its Annual Report on Form 20-F, which included audited financial statements for the fiscal year ended March 31, 2011. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at www.sec.gov and can also be found at the Investor Relations Section of CCBC's website at http://ir.chinacordbloodcorp.com. CCBC will provide a hard copy of the Annual Report, including a complete set of audited financial statements, free of charge to its shareholders upon request.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, performance and results of operations, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the U.S. Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:


China Cord Blood Corporation

Ms. Joeling Law

Tel: (+852) 3605-8180

Email: ir@chinacordbloodcorp.com


ICR, Inc.

In New York: Ashley Ammon De Simone: 1-646-277-1227

In Beijing: Wen Lei Zheng: +86-10-6583-7510



SOURCE China Cord Blood Corporation



GLTA... KarinCA ;)

"Be kinder than necessary, for everyone you meet is fighting some kind of battle."


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist